Literature DB >> 19019729

Differential patterns of amantadine-resistance in influenza A (H3N2) and (H1N1) isolates in Toronto, Canada.

Rachel R Higgins1, A Eshaghi, L Burton, T Mazzulli, S J Drews.   

Abstract

BACKGROUND: Molecular methods were used to characterize influenza A (H1N1) and (H3N2) strains and to identify amantadine-resistance.
OBJECTIVES: To compare proportions of amantadine-resistant influenza A (H1N1) and (H3N2) isolates in the Greater Toronto Area. STUDY
DESIGN: Isolates of influenza A (H1N1) and (H3N2) were strain typed using molecular methods. Pyrosequencing for point mutations in the transmembrane domain of the M2 proton channel was undertaken. Proportions of amantadine-resistant and susceptible isolates were compared using the The Fisher's exact test.
RESULTS: 96% of the 49 influenza A (H3N2) isolates and none of the influenza A (H1N1) tested carried a point mutation in the M gene coding for the M2 protein. Influenza A (H3N2) isolates were more likely to carry an amantadine-resistance associated mutation than influenza A (H1N1) isolates (Fishers's exact test, P<0.0001).
CONCLUSIONS: : Characterization of amantadine-resistance in influenza A (H1N1) isolates should utilize a variety of different methods including sub-typing, strain typing, and direct sequencing for point mutations associated with amantadine-resistance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19019729     DOI: 10.1016/j.jcv.2008.10.001

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  9 in total

1.  Adamantane resistance in seasonal human influenza A viruses from Calgary, Alberta (January 2007 to August 2008).

Authors:  Kanti Pabbaraju; Sallene Wong; Dmitri K Kits; Julie D Fox
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

2.  SARS-CoV-2, Zika viruses and mycoplasma: Structure, pathogenesis and some treatment options in these emerging viral and bacterial infectious diseases.

Authors:  Gonzalo Ferreira; Axel Santander; Florencia Savio; Mariana Guirado; Luis Sobrevia; Garth L Nicolson
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-09-03       Impact factor: 5.187

Review 3.  Deep sequencing: becoming a critical tool in clinical virology.

Authors:  Miguel E Quiñones-Mateu; Santiago Avila; Gustavo Reyes-Teran; Miguel A Martinez
Journal:  J Clin Virol       Date:  2014-06-24       Impact factor: 3.168

4.  Switching gears for an influenza pandemic: validation of a duplex reverse transcriptase PCR assay for simultaneous detection and confirmatory identification of pandemic (H1N1) 2009 influenza virus.

Authors:  Jason J LeBlanc; Yan Li; Nathalie Bastien; Kevin R Forward; Ross J Davidson; Todd F Hatchette
Journal:  J Clin Microbiol       Date:  2009-09-30       Impact factor: 5.948

Review 5.  Antiviral drugs for viruses other than human immunodeficiency virus.

Authors:  Raymund R Razonable
Journal:  Mayo Clin Proc       Date:  2011-10       Impact factor: 7.616

6.  San Wu Huangqin Decoction, a Chinese Herbal Formula, Inhibits Influenza a/PR/8/34 (H1N1) Virus Infection In Vitro and In Vivo.

Authors:  Qinhai Ma; Qingtian Yu; Xuefeng Xing; Sinian Liu; Chunyu Shi; Jiabo Luo
Journal:  Viruses       Date:  2018-03-09       Impact factor: 5.048

7.  The feasibility of using high resolution genome sequencing of influenza A viruses to detect mixed infections and quasispecies.

Authors:  Muthannan A Ramakrishnan; Zheng Jin Tu; Sushmita Singh; Ashok K Chockalingam; Marie R Gramer; Ping Wang; Sagar M Goyal; My Yang; David A Halvorson; Srinand Sreevatsan
Journal:  PLoS One       Date:  2009-09-22       Impact factor: 3.240

Review 8.  The Role of Clinical Virology Laboratory and the Clinical Virology Laboratorian in Ensuring Effective Surveillance for Influenza and Other Respiratory Viruses: Points to Consider and Pitfalls to Avoid.

Authors:  Steven J Drews
Journal:  Curr Treat Options Infect Dis       Date:  2016-07-05

Review 9.  Emerging molecular assays for detection and characterization of respiratory viruses.

Authors:  Wenjuan Wu; Yi-Wei Tang
Journal:  Clin Lab Med       Date:  2009-12       Impact factor: 1.935

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.